NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Investor Presentation, 14 March 2023, page-13

  1. 2,565 Posts.
    lightbulb Created with Sketch. 394
    Thanks I understand they can leverage the detail - just wondering if that alleviates the need for additional local trials?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.